KA-EX Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$6.08M
- Investors
-
4
KA-EX General Information
Description
Developer of a clinically tested cortisol stress reduction supplement designed for athletes and high-performers seeking faster recovery, better sleep and sustained daily energy. The company offers a citrus-flavored recovery product formulated with phosphatidylserine, amino acids, electrolytes, antioxidants, and functional carbohydrates that help replenish muscle glycogen, support muscle repair, restore acid-base balance, and improve sleep quality, enabling competitive and recreational athletes, sports teams, and other high-performers to reduce stress-related performance plateaus, enhance mood, boost immune resilience, and maximize training progress.
Contact Information
Website
www.ka-ex.comCorporate Office
- Friesenbergstrasse 75
- 8055 Zurich
- Switzerland
Corporate Office
- Friesenbergstrasse 75
- 8055 Zurich
- Switzerland
KA-EX Timeline
KA-EX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Equity Crowdfunding | 01-Apr-2026 | $6.08M | Completed | Generating Revenue | ||
| 11. Later Stage VC | 20-Feb-2026 | Completed | Generating Revenue | |||
| 10. Equity Crowdfunding | 28-Jan-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 12-Jul-2024 | Completed | Generating Revenue | |||
| 8. Equity Crowdfunding | 31-May-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 20-Feb-2023 | Completed | Generating Revenue | |||
| 6. Equity Crowdfunding | 30-Apr-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 31-Mar-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 14-Sep-2021 | $1.95M | $3.1M | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | 01-Jan-2020 | $1.15M | Completed | Startup |
KA-EX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A2 | ||||||||
| Series A2 | ||||||||
| Series A2 | ||||||||
| Series A Preference | ||||||||
| Series A Preference | ||||||||
| Series A Preference | ||||||||
| Series A Preference | ||||||||
| Ordinary | 3,408 | $1.117071 | $32.77 | $32.77 | 1x | $32.77 | 1.57% | |
| Ordinary | 1,136 | $1.117071 | $59 | $59 | 1x | $59 | 0.52% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
KA-EX Comparisons
Industry
Financing
Details
KA-EX Competitors (3)
One of KA-EX’s 3 competitors is AG1, a Venture Capital-Backed company based in Carson City, NV.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AG1 | Venture Capital-Backed | Carson City, NV | ||||
| Nelson Liquid Drive | Private Equity-Backed | Fenton, MI | ||||
| Morningside Recovery | Corporate Backed or Acquired | Huntington Beach, CA |
KA-EX Patents
KA-EX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3493816-A1 | Composition for the treatment of veisalgia | Inactive | 04-Aug-2016 | ||
| US-20190350888-A1 | Composition for the treatment of veisalgia | Inactive | 04-Aug-2016 | ||
| US-20220096413-A1 | Method of using composition for treatment of veisalgia | Inactive | 04-Aug-2016 | A61K31/7004 |
KA-EX Signals
KA-EX Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| mediaforgrowth | Growth/Expansion | Minority | ||
| Artemon | PE/Buyout | Minority | ||
| German Media Pool | Venture Capital | Minority | ||
| ProSiebenSat.1 Licensing | Corporation |
KA-EX Acquisitions (1)
KA-EX’s most recent deal was a Merger/Acquisition with ViCAP Global. The deal was made on 28-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ViCAP Global | 28-Jul-2025 | Merger/Acquisition | Other Containers and Packaging |
KA-EX Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ViCAP Global | Zürich, Switzerland | 2006 |
KA-EX FAQs
-
When was KA-EX founded?
KA-EX was founded in 2016.
-
Where is KA-EX headquartered?
KA-EX is headquartered in Zurich, Switzerland.
-
What is the size of KA-EX?
KA-EX has 27 total employees.
-
What industry is KA-EX in?
KA-EX’s primary industry is Food Products.
-
Is KA-EX a private or public company?
KA-EX is a Private company.
-
What is KA-EX’s current revenue?
The current revenue for KA-EX is .
-
How much funding has KA-EX raised over time?
KA-EX has raised $31.6M.
-
Who are KA-EX’s investors?
mediaforgrowth, Artemon, German Media Pool, and ProSiebenSat.1 Licensing have invested in KA-EX.
-
Who are KA-EX’s competitors?
AG1, Nelson Liquid Drive, and Morningside Recovery are competitors of KA-EX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process